-
1دورية أكاديمية
المؤلفون: Rugo, Hope S, Harmer, Victoria, O’Shaughnessy, Joyce, Jhaveri, Komal, Tolaney, Sara M, Cardoso, Fatima, Bardia, Aditya, Maheshwari, Vikalp Kumar, Tripathi, Sandeep, Haftchenary, Sina, Pathak, Purnima, Fasching, Peter A
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Cancer, Clinical Research, Breast Cancer, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, abemaciclib, CDK4, inhibitor, MONALEESA-2, MONARCH 3, quality of life, ribociclib, CDK4/6 inhibitor, Oncology and carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/7qf8665qTest
-
2دورية أكاديمية
المؤلفون: Stephen Johnston (767275), Joyce O’Shaughnessy (5844761), Miguel Martin (69983), Jens Huober (8117480), Masakazu Toi (181141), Joohyuk Sohn (135694), Valérie AM André (10788196), Holly R Martin (10788199), Molly C Hardebeck (10788201), Matthew P Goetz (8574168)
مصطلحات موضوعية: Cancer, Medical and Health Sciences not elsewhere classified, Biological Sciences not elsewhere classified, metastasis, breast cancer, Phase III trials, MONARCH 3, Abemaciclib
-
3
المؤلفون: Hope S. Rugo, Victoria Harmer, Joyce O’Shaughnessy, Komal Jhaveri, Sara M. Tolaney, Fatima Cardoso, Aditya Bardia, Vikalp Kumar Maheshwari, Sandeep Tripathi, Sina Haftchenary, Purnima Pathak, Peter A. Fasching
المصدر: Therapeutic Advances in Medical Oncology. 15:175883592311528
مصطلحات موضوعية: CDK4, Clinical Trials and Supportive Activities, Evaluation of treatments and therapeutic interventions, abemaciclib, CDK4/6 inhibitor, inhibitor, quality of life, Oncology, Clinical Research, MONARCH 3, 6.1 Pharmaceuticals, Breast Cancer, MONALEESA-2, ddc:610, ribociclib, Cancer
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d26777176da859f84af9f0abc42ea179Test
https://doi.org/10.1177/17588359231152843Test